Cherry Biotech
Develops organoid culture systems and preclinical testing services for drug developers and life-science researchers
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-30
About Cherry Biotech
Cherry Biotech develops microfluidic systems for 3D cell culture and organoid research, including CubiX and OrganoidPlate. It also provides contract research services using in vitro human organ models to assess drug candidates.
Customers include drug developers and research laboratories seeking organoid models, equipment, or custom preclinical studies. The company sells scientific instruments and provides contract research services.
Founded in 2014, Cherry Biotech is headquartered in Montreuil, France. Its stated work combines microfluidics, imaging, multi-omics and AI; its careers information describes CubiX as in pre-sales and CRO services as active.
Product: Microfluidic 3D cell-culture and organoid systems, plus contract research services for preclinical drug studies.
Jobs at Cherry Biotech (1)
Cherry Biotech is hiring for one role in finance, based in Montreuil.
Finance & Admin Intern
New on Evolc
Leadership
- Dario Fassini · Late Founder - CSO & Head of Preclinical Model DevelopementSource: company website
- Pierre Gaudriault · Late Founder - Scientific Chief Business DeveloperSource: company website
- Jeremy Cramer · Co-Founder & CEOSource: company website
More biotech & pharma companies
Chromagar
Chromogenic culture media for clinical, food, water-testing and veterinary microbiology laboratoriesNew on EvolcCilcare
Preclinical auditory research and drug-development services for pharmaceutical, biotech and medical-device partnersNew on EvolcCorwave
Heart-assist pumps for heart failure patients, developed by a Paris-area medical device company in clinical stageNew on EvolcRemote-friendlyCrossject
Needle-free auto-injector ZENEO® and emergency drug candidates for epilepsy, adrenal crisis and anaphylaxisNew on EvolcCtibiotech
Human tissue and 3D cell models with drug screening and preclinical testing for pharma and cosmetics firmsNew on EvolcCure 51
Cancer target discovery platform using exceptional survivor biology for pharmaceutical and oncology research partnersYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- CookieYes
- Elementor
- Google Ads
- Google Analytics 4
- Google Tag Manager
- WooCommerce
- WordPress
- jQuery
